Congress Returns. The House and Senate will be back in session on September 9, 2024, with a joint focus on completing consideration of a continuing resolution (CR) to maintain government funding beyond the end of fiscal year...more
9/6/2024
/ Abortion ,
Congressional Committees ,
DEA ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Pharmaceutical Industry ,
Prescription Drugs ,
Reproductive Healthcare Issues ,
Roe v Wade ,
SCOTUS ,
Telehealth
CMS Finalizes New TCET Pathway. The final procedural notice, effective immediately, creates a new pathway that uses existing national coverage determination and coverage with evidence development (CED) processes to expedite...more
House Oversight and Accountability Committee Holds Hearing on PBMs. Republicans and Democrats shared concerns about the role and practices of PBMs. While generally supportive of free market principles, Republicans criticized...more
A Quiet Healthcare Week on Capitol Hill. Congress was largely in recess this week, although the Senate returned briefly to complete consideration of a long-awaited foreign aid bill. Both chambers will return to session the...more
4/26/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Federal Trade Commission (FTC) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Healthcare ,
Healthcare Reform ,
HRSA ,
Legislative Agendas ,
Medicaid ,
Medicare ,
Non-Compete Agreements ,
Nursing Homes ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Legislation ,
Section 340B ,
Senate Committees ,
Skilled Nursing Facility ,
U.S. House
Appropriations Update. On March 3, Congress released bill text for the CAA, 2024, which includes funding for six of the 12 appropriations bills: Agriculture-FDA, Military Construction-VA, Energy-Water, Transportation-HUD,...more
3/11/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Drug Pricing ,
Federal Trade Commission (FTC) ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
HELP Act ,
Legislative Agendas ,
Medicare ,
Medicare Advantage ,
Pharmaceutical Industry ,
Prescription Drugs ,
Private Equity ,
Proposed Legislation ,
Senate Committees ,
U.S. House
Appropriations Update. As appropriators continue to finalize the 12 funding bills for fiscal year (FY) 2024 – which began on October 1, 2023 – a series of stopgap CRs have been needed to avoid a government shutdown. This...more
3/4/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Payment Systems ,
Pharmaceutical Industry ,
Prescription Drugs ,
SAMHSA ,
Senate Banking Committee ,
Senate Committees
House Passes Legislation to Prohibit Use of QALYs in All Federal Health Programs. The House passed H.R. 485, the Protecting Health Care for All Patients Act of 2023, a bill designed to prohibit the use of QALYs and similar...more
2/9/2024
/ Artificial Intelligence ,
Congressional Committees ,
Health Care Providers ,
Healthcare ,
HELP ,
HRSA ,
Information Technology ,
OCR ,
Pharmaceutical Industry ,
Prescription Drugs ,
SAMHSA ,
U.S. House
House Energy and Commerce Committee Holds Hearing on Healthcare Costs. The hearing included discussion on what factors are causing cost increases for individuals, for the healthcare sector, and for federal health programs...more
2/2/2024
/ Centers for Medicare & Medicaid Services (CMS) ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicare Advantage ,
Medicare Part D ,
Mental Health ,
Pharmaceutical Industry ,
Prescription Drugs ,
SAMHSA ,
Senate Committees ,
Substance Abuse ,
Telehealth ,
U.S. House
House Passes Healthcare Legislation. The House brought two key bipartisan healthcare bills to the floor this week. The Lower Costs, More Transparency Act (H.R. 5378) was approved by a vote of 320–71, and the Support for...more
12/18/2023
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
GAO ,
Healthcare ,
Healthcare Reform ,
HELP ,
Legislative Agendas ,
Medicare ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Privacy Laws ,
Proposed Legislation ,
Senate Committees ,
Technology Sector ,
U.S. House
Senate Finance Committee Examines Drug Shortages. The hearing addressed concerns and explored potential solutions related to drug shortages in the United States, particularly focusing on essential medications. The hearing...more
12/11/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Healthcare ,
Healthcare Reform ,
HELP ,
March-in-Rights ,
NIST ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Price Transparency ,
Request For Information ,
Telehealth ,
U.S. Commerce Department
CONGRESS -
Senate Finance Committee Holds Markup on Better Mental Health Care, Lower-Cost Drugs, and Extenders Act. The bipartisan package includes Medicare and Medicaid extenders, provisions to expand the mental health...more
11/10/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Hospitals ,
Legislative Agendas ,
Medicare ,
Mental Health ,
National Institute of Health (NIH) ,
Outpatient Prospective Payment System (OPPS) ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Physician Fee Schedule ,
Prescription Drugs ,
Regulatory Agenda ,
Senate Committees ,
Telehealth ,
U.S. House
On November 2, 2023, the Centers for Medicare and Medicaid Services (CMS) finalized the rule Medicare Program; Hospital Outpatient Prospective Payment System: Remedy for the Calendar Years 2018–2022 to addresses how the...more
11/6/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Drug Pricing ,
Final Rules ,
Healthcare ,
Healthcare Facilities ,
Healthcare Reform ,
Hospitals ,
Medical Reimbursement ,
Outpatient Prospective Payment System (OPPS) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Section 340B
CONGRESS -
House Republicans Release Healthcare Package. On September 6, House Republicans unveiled the Lower Costs, More Transparency Act, a draft package of healthcare transparency provisions, pharmacy benefit manager...more
9/11/2023
/ Artificial Intelligence ,
Centers for Medicare & Medicaid Services (CMS) ,
CMMI ,
Congressional Committees ,
Department of Health and Human Services (HHS) ,
Department of Labor (DOL) ,
Disability Discrimination ,
Drug Pricing ,
Fair Labor Standards Act (FLSA) ,
Healthcare ,
Healthcare Reform ,
HELP ,
Legislative Agendas ,
Long Term Care Facilities ,
Long-Term Care ,
New Legislation ,
Over-Time ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Legislation ,
Proposed Rules ,
Request For Information ,
Rural Health Care Program ,
Transparency
The House was in session this week, while the Senate was in recess. The House Energy & Commerce Committee continued its work on healthcare by advancing six bills that address competition, transparency and access to care. The...more
5/30/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Department of Health and Human Services (HHS) ,
Health Care Providers ,
Healthcare ,
Medicaid ,
New Legislation ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Proposed Legislation ,
Transparency
The House and Senate were both in session this week, with significant healthcare activity at the committee level. The House Ways & Means Committee met to discuss healthcare price transparency, and the Ways & Means Health...more
5/19/2023
/ Abortion ,
Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Committees ,
Coronavirus/COVID-19 ,
Data Privacy ,
Data Protection ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
GAO ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicare Advantage ,
New Legislation ,
New Regulations ,
Non-Compete Agreements ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Price Transparency ,
Proposed Legislation ,
Proposed Regulation ,
Regulatory Agenda ,
Ways and Means Committee
The House and Senate were both in session this week. The House Ways & Means Health Subcommittee met to discuss policies inhibiting innovation and patient access, and the House Energy & Commerce Health Subcommittee held a...more
5/12/2023
/ Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
DEA ,
Deadlines ,
GAO ,
Healthcare ,
HELP ,
Legislative Agendas ,
Patient Access ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Health Emergency
Congress was in session, and it was a busy healthcare week at the committee level, with six hearings focused specifically on health issues. On the House floor, Republicans passed the Limit, Save, Grow Act—a bill that raises...more
5/2/2023
/ Abortion ,
Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Congressional Investigations & Hearings ,
Coronavirus/COVID-19 ,
DACA ,
Department of Health and Human Services (HHS) ,
Enforcement Actions ,
Federal Funding ,
Health Insurance ,
Healthcare ,
Healthcare Reform ,
HELP ,
Hospitals ,
Medicaid ,
New Legislation ,
Pharmaceutical Industry ,
Prescription Drugs ,
Price Transparency ,
Proposed Legislation ,
Proposed Rules ,
Right of Access
Lots of Healthcare Activity in Congress -
Activity in Congress focusing on healthcare issues has increased over the last few weeks and is not slowing down anytime soon. This week, the Senate Health, Education, Labor, and...more
5/1/2023
/ Centers for Medicare & Medicaid Services (CMS) ,
Coronavirus/COVID-19 ,
Drug Pricing ,
Health Care Providers ,
Healthcare ,
HELP ,
Medicaid ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Proposed Legislation ,
Proposed Rules ,
State Medicaid Programs ,
Transparency